Journal of Alzheimer’s Disease partners with Advanced Continuing Education Association to launch new CME article series

July 15, 2019 - Amsterdam and Boston - The Journal of Alzheimer’s Disease (JAD) is pleased to announce a new partnership with the Advanced Continuing Education Association (ACEA) to provide a new series of fully accredited continuing medical education (CME) journal articles. The program, accredited under the ACCME and open to US and Canadian physicians, launches today with 10 landmark articles published in JAD, each with a corresponding CME post-test providing 1.0 AMA PRA Category 1 Credit™. More...

July 15, 2019

New Analysis Shows Drug Slows Down Respiratory Decline in Patients with Duchenne Muscular Dystrophy in Three Clinical Trials

Comparison of clinical trial results with prospective natural history data published in the Journal of Neuromuscular Diseases show supportive results for eteplirsen in delaying respiratory decline

July 9, 2019 - Amsterdam, NL – Duchenne muscular dystrophy occurs in boys and is characterized by progressive muscle degeneration and weakness leading to a decline in respiratory function. Strategies to arrest this severe progressive deterioration are needed to extend lives and improve quality of life. Results of three clinical trials using eteplirsen, an exon-skipping antisense oligonucleotide, show promising results, according to a study published in the Journal of Neuromuscular Diseases. More...

July 9, 2019

Yan-Jiang Wang and Xian-Le Bu Receive 2019 Alzheimer Award

This award recognizes outstanding contributions to the advancement of AD research published in the Journal of Alzheimer's Disease

July 2, 2019 - Amsterdam, NL – The Journal of Alzheimer's Disease (JAD) is pleased to announce that Yan-Jiang Wang, MD, PhD, and Xian-Le Bu, MD, PhD, both of Daping Hospital, Third Military Medical University, Chongqing, China, are joint recipients of the 2019 Alzheimer Award. More...

July 2, 2019

IOS Press Journal Impact Factors show a steady rise

June 21, 2019 - Amsterdam, June 21, 2019 – IOS Press, an independent international publisher of scientific, technical and medical (STM) journals and books, announces an overall Impact Factor increase of more than 12% across its 27 journals currently covered in the 2019 Journal Citation Reports®* (based on 2018 data), which was published this week. Journals in AI and Computer Science achieved the most significant gains. More...

June 21, 2019